NCT06231680 2024-03-29
Thalidomide Prevention or Treatment of Camrelizumab-induced Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP)
Henan Cancer Hospital
Phase 2 Unknown
Clinical Trials
12 trialsNCT05688020 2023-08-09
Tranexamic Acid During Upper GI Endoscopic Resection Procedures
Assaf-Harofeh Medical Center
Phase 4 Unknown
NCT05007145 2021-12-21
REVO
Fujian Cancer Hospital
Phase 2 Unknown
NCT05013697 2021-08-19
TQB2450 Solution for Injection (TQB2450)+Paclitaxel+Cisplatin ± Anlotinib in the Treatment of Esophageal Cancer.
Henan Cancer Hospital
Phase 2 Unknown
NCT03985670 2019-12-12
Teripalimab Plus Chemotherapy in Local Advanced Esophageal Cancer
Henan Cancer Hospital
Phase 2 Unknown
NCT04158414 2019-11-08
Applying PET/MR in Oncology - a Prospective Project
Tel-Aviv Sourasky Medical Center
Phase NA Unknown
NCT02741856 2018-10-25
SCOPE2
Velindre NHS Trust
Phase 2/3 Unknown
NCT02924909 2018-03-20
QUIMERA
Instituto Nacional de Cancer, Brazil
Phase 2 Unknown
NCT03415815 2018-01-30
An Observational Study to Evaluate Lymph Metastases and Prognoses of the Patients With Esophageal Cancer
Henan Cancer Hospital
Unknown
NCT01843829 2014-03-24
NeoSCOPE
Velindre NHS Trust
Phase 2 Unknown
NCT00453323 2010-07-12
Paclitaxel and Capecitabine in Patients With Metastatic/Recurrence Esophageal Cancer
National Cancer Center, Korea
Phase 2 Unknown
NCT00193817 2006-02-07
Three Field Radical Esophagectomy Versus Two Field Esophagectomy - a Prospective Trial
Tata Memorial Hospital
Phase 3 Unknown